top of page
ASG Receives U.S. FDA IND Approval to Initiate Phase 1 Clinical Trial of the Lead Drug Beta1 for Male Erectile Dysfunction
ASG received Investigational New Drug (IND) application clearance from the U.S. Food and Drug Administration (FDA). Beta1 is currently the only inhaled investigational therapy for male erectile dysfunction to have received such approval and prepared to enter clinical trial
bottom of page